Skip to main content

Main navigation

  • About
    • Members
    • Our Team
    • Annual Report
    • Rutgers-NPC Health Policy & Communications Fellowship
    • NPC Summer Scholars
    • Contact Us
  • Topics
    • Health Spending
      • IRA & Medicare Drug Price Negotiation
      • 340B Drug Pricing Program
      • Understanding Health Spending
      • Low-Value Care
      • Health Spend Management
    • Value Assessment
      • Value Assessment Frameworks
      • Value Assessment Methods
      • Elements of Value
    • Alternative Payment Models
      • Value-Based Contracts
      • Regulatory Barriers & Challenges
      • Paying for Cures
      • Accountable Care Organizations
      • Bundled Payments
      • Health Care Quality Measures
      • Clinical Pathways
    • Patient-Centered Formulary & Benefit Design
      • High-Deductible Health Plans
      • Value-Based Insurance Design
      • Utilization Management & Step Therapy
      • Formulary Development
      • Patient Cost Sharing
      • Individual Treatment Effects & Personalized Access
    • Evidence for Decision Making
      • Real-World Data
      • Real-World Evidence
      • Good Practices for Evidence
    • Biopharma Innovation
      • Impact on Outcomes & Spending
  • Resources
    • Research
    • Fact Sheets
    • Policy & Evidence Briefs
    • Letters & Comments
    • E.V.I.dently Today Blog
    • Newsletters
    • Events
    • CER Daily Newsfeed®
    • Press Room
      • NPC in the News
      • NPC Press Releases
    • Videos and Graphics
    • Stakeholder Resources
      • For Employers
      • For Patient Organizations
      • Going Below The Surface
  • Get Involved
    • Become a Member
    • Submit a Research Proposal
    • Start a Career
  • Members Only
    • Value of Membership
      • Strategic Plan
      • Research Pipeline
    • Member Resources
      • Weekly Leadership Memo
      • Government Price-Setting & IRA Implementation Member Resources
      • Value Assessment & ICER-Related Member Resources
      • Health Spending & Drug Pricing Member Resources
      • Other Policy-Relevant Member Resources
    • Member Events
      • Leadership Forums
    • Board of Directors
    • Committees & Workgroups
      • Audit & Budget
      • Board-Level Research Committee
      • Executive Committee
      • Strategic Advisory Group
      • Corresponding Officers
      • Research Work Group
      • Employer Work Group
      • Policy & Communications Work Group
    • Logout
National Pharmaceutical Council

Offscreen menu

User account menu

  • Member Resources

Study Links 340B Expansion With Higher ACA Premiums

  • Read more about Study Links 340B Expansion With Higher ACA Premiums

The Association of the 340B Program With Affordable Care Act (ACA) Premiums: A Longitudinal Analysis From 2018 to 2022

  • Read more about The Association of the 340B Program With Affordable Care Act (ACA) Premiums: A Longitudinal Analysis From 2018 to 2022

Access to Fair Prescription Plans Can Make Employees Healthier

  • Read more about Access to Fair Prescription Plans Can Make Employees Healthier

Prescription Drug Utilization and Spending by Race, Ethnicity, Payer, Health Condition, and US State

  • Read more about Prescription Drug Utilization and Spending by Race, Ethnicity, Payer, Health Condition, and US State

New Study Reveals Significant Racial and Ethnic Disparities in Prescription Drug Utilization and Spending Across the United States

  • Read more about New Study Reveals Significant Racial and Ethnic Disparities in Prescription Drug Utilization and Spending Across the United States

Yevgeniy Feyman, PhD

  • Read more about Yevgeniy Feyman, PhD

Reducing Workforce Health and Well-Being Inequities Is Good for Business

  • Read more about Reducing Workforce Health and Well-Being Inequities Is Good for Business

Kenneth Finegold, PhD

  • Read more about Kenneth Finegold, PhD

What you need to know about copay accumulators and maximizers

  • Read more about What you need to know about copay accumulators and maximizers

Copay Accumulator And Maximizer Programs: Stakes Rise For Patients As Federal Rulemaking Lags

  • Read more about Copay Accumulator And Maximizer Programs: Stakes Rise For Patients As Federal Rulemaking Lags

Pagination

  • Page 1
  • Next page
Subscribe to Patient Cost Sharing

Let's stay in touch.

Subscribe to our newsletter.
© 2026 NPC. All rights reserved.

Footer Menu

  • Accessibility
  • Privacy Policy
  • Terms of Use
  • Contact Us

Footer Social Links Menu

  • Twitter image/svg+xml
  • Linkedin
  • Youtube